Inhibition of the antigen-induced activation of RBL-2H3 cells by sinomenine

International Immunopharmacology

Volumn 8, Issue 3, 2008, Pages 502-507

  Huang, Feng ^a,b   Yamaki, Kouya ^a   Tong, Xiaoyun ^c   Fu, Lianqing ^d   Zhang, Ronghua ^b   Cai, Yu ^b   Yanagisawa, Rie ^e   Inoue, Ken ichiro ^e   Takano, Hirohisa ^e   Yoshino, Shin ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b JINAN UNIVERSITY   (China)

^c GUANGZHOU UNIVERSITY   (China)

^d Beijing 307 Hospital   (China)

^e NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

Author keywords

Akt; ; Gab2; ; p38 MAPK; RBL 2H3 cells; ; Sinomenine;

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 2,4 DINITROPHENOL; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADAPTOR PROTEIN; ALKALOID; ANTIGEN; BETA N ACETYLHEXOSAMINIDASE; CALCIUM; CYTOKINE; FC EPSILON RI; FC RECEPTOR; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN E; INTERLEUKIN 4; LAT PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN GAB2; PROTEIN KINASE B; SINOMENINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOBLOTTING; IMMUNOREGULATION; MAST CELL DEGRANULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SINOMENIUM; SINOMENIUM ACUTUM; SUPERNATANT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS; BETA-N-ACETYLHEXOSAMINIDASES; CALCIUM; CELLS, CULTURED; INTERLEUKIN-4; MAST CELLS; MORPHINANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39149108462     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.12.009     Document Type: Article

References (22)

1. Liu L., Riese J., Resch K., and Kaever V. Impairment of macrophage eicosanoid and nitric oxide production by an alkaloid from Sinomenium acutum. Arzneimittelforschung 44 11 (1994) 1223-1226
2. Liu L., Resch K., and Kaever V. Inhibition of lymphocyte proliferation by the anti-arthritic drug sinomenine. Int J Immunopharmacol 16 8 (1994) 685-691
3. Liu L., Buchner E., Beitze D., Schmidt-Weber C.B., Kaever V., Emmrich F., et al. Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. Int J Immunopharmacol 18 10 (1996) 529-543
4. Feng H., Yamaki K., Takano H., Inoue K., Yanagisawa R., and Yoshino S. Suppression of Th1 and Th2 immune responses in mice by Sinomenine, an alkaloid extracted from the chinese medicinal plant Sinomenium acutum. Planta Med 72 15 (2006) 1383-1388
5. McDermott R.A., Porterfield H.S., Mezayen R.E., Burks A.W., Pons L., Schlichting D.G., et al. Contribution of Ara h 2 to peanut-specific, immunoglobulin E-mediated, cell activation. Clin Exp Allergy 37 5 (2007) 752-763
6. Marchand F., Mecheri S., Guilloux L., Iannascoli B., Weyer A., and Blank U. Human serum IgE-mediated mast cell degranulation shows poor correlation to allergen-specific IgE content. Allergy 58 10 (2003) 1037-1043
7. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 1-2 (1983) 55-63
8. Matsubara M., Masaki S., Ohmori K., Karasawa A., and Hasegawa K. Differential regulation of IL-4 expression and degranulation by anti-allergic olopatadine in rat basophilic leukemia (RBL-2H3) cells. Biochem Pharmacol 67 7 (2004) 1315-1326
9. Giudice E.D., Rinaldi L., Passarotto M., Facchinetti F., D'Arrigo A., Guiotto A., et al. Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells. J Leukoc Biol 81 6 (2007) 1512-1522
10. Wang Q., Matsuda H., Matsuhira K., Nakamura S., Yuan D., Yoshikawa M., et al. Inhibitory effects of thunberginols A, B, and F on degranulations and releases of TNF-alpha and IL-4 in RBL-2H3 cells. Biol Pharm Bull 30 2 (2007) 388-392
11. Linwong W., Hirasawa N., Aoyama S., Hamada H., Saito T., and Ohuchi K. Inhibition of the antigen-induced activation of rodent mast cells by putative Janus kinase 3 inhibitors WHI-P131 and WHI-P154 in a Janus kinase 3-independent manner. Br J Pharmacol 145 6 (2005) 818-828
12. Blank U., and Rivera J. The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol 25 5 (2004) 266-273
13. Saitoh S., Arudchandran R., Manetz T.S., Zhang W., Sommers C.L., Love P.E., et al. LAT is essential for Fc(epsilon)RI-mediated mast cell activation. Immunity 12 5 (2000) 525-535
14. Gu H., Saito K., Klaman L.D., Shen J., Fleming T., Wang Y., et al. Essential role for Gab2 in the allergic response. Nature 412 6843 (2001) 186-190
15. Parravicini V., Gadina M., Kovarova M., Odom S., Gonzalez-Espinosa C., Furumoto Y., et al. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat Immunol 3 8 (2002) 741-748
16. Yu M., Lowell C.A., Neel B.G., and Gu H. Scaffolding adapter Grb2-associated binder 2 requires Syk to transmit signals from FcepsilonRI. J Immunol 176 4 (2006) 2421-2429
17. Fukao T., Terauchi Y., Kadowaki T., and Koyasu S. Role of phosphoinositide 3-kinase signaling in mast cells: new insights from knockout mouse studies. J Mol Med 81 9 (2003) 524-535
18. Chan J.H., Liao W., Lau H.Y., and Wong W.S. Gab2 antisense oligonucleotide blocks rat basophilic leukemic cell functions. Int Immunopharmacol 7 7 (2007) 937-944
19. Hirasawa N., Sato Y., Fujita Y., and Ohuchi K. Involvement of a phosphatidylinositol 3-kinase-p38 mitogen activated protein kinase pathway in antigen-induced IL-4 production in mast cells. Biochim Biophys Acta 1456 1 (2000) 45-55
20. Frossi B., Rivera J., Hirsch E., and Pucillo C. Selective activation of Fyn/PI3K and p38 MAPK regulates IL-4 production in BMMC under nontoxic stress condition. J Immunol 178 4 (2007 15) 2549-2555
21. Kitaura J., Asai K., Maeda-Yamamoto M., Kawakami Y., Kikkawa U., and Kawakami T. Akt-dependent cytokine production in mast cells. J Exp Med 192 5 (2000) 729-740
22. Koranteng R.D., Swindle E.J., Davis B.J., Dearman R.J., Kimber I., Flanagan B.F., et al. Differential regulation of mast cell cytokines by both dexamethasone and the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580. Clin Exp Immunol 137 1 (2004) 81-87